THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 126 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,515,510 | -16.6% | 7,012,226 | 0.0% | 8.59% | -45.8% |
| Q2 2023 | $72,576,538 | -4.6% | 7,012,226 | 0.0% | 15.84% | -3.2% |
| Q1 2023 | $76,082,653 | -3.3% | 7,012,226 | 0.0% | 16.36% | +17.4% |
| Q4 2022 | $78,677,176 | +10.7% | 7,012,226 | 0.0% | 13.94% | -8.6% |
| Q3 2022 | $71,104,000 | +8.0% | 7,012,226 | -3.5% | 15.26% | +13.2% |
| Q2 2022 | $65,862,000 | -99.9% | 7,269,584 | 0.0% | 13.47% | +3.8% |
| Q1 2022 | $69,497,223,000 | +94504.2% | 7,269,584 | +9.3% | 12.98% | -18.4% |
| Q4 2021 | $73,461,000 | +101.4% | 6,648,025 | +34.9% | 15.90% | +96.8% |
| Q3 2021 | $36,478,000 | – | 4,929,423 | – | 8.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |